ID
11728
Descrizione
Ticagrelor is a new, reversible binding, anti-platelet medication. Anti-platelet medications work to prevent the formation of blood clots. Ticagrelor is being developed as a treatment for patients with acute coronary syndrome (ACS). ACS is a term that is used to describe both heart attacks in progress or the imminent threat of a heart attack. ACS is usually caused by the formation of a blood clot in an artery that partially or totally blocks the blood supply to a portion of the heart muscle. Ticagrelor will be compared with clopidogrel to determine which drug, when either is used in conjunction with aspirin, is better at reducing deaths from vascular causes, future heart attacks and/or strokes in patients with ACS. https://clinicaltrials.gov/ct2/show/NCT00391872
collegamento
https://clinicaltrials.gov/ct2/show/NCT00391872
Keywords
versioni (1)
- 28/07/15 28/07/15 -
Caricato su
28 luglio 2015
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY 4.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
Eligibility PLATO Acute Coronary Syndrome NCT00391872
Eligibility Criteria
- StudyEvent: ODM
Descrizione
Exclusion Criteria
Descrizione
moderate or severe liver disease
Tipo di dati
boolean
Alias
- UMLS CUI-1
- C0085605
Descrizione
treated with blood clotting agents that cannot be stopped
Tipo di dati
boolean
Alias
- UMLS CUI-1
- C0280087
Descrizione
already been treated with an invasive (angioplasty) procedure
Tipo di dati
boolean
Alias
- UMLS CUI-1
- C0190211
Similar models
Eligibility Criteria
- StudyEvent: ODM